Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More R&D Westlake to Construct Membrane Chlor-Alkali Unit in LousianaBayer CropScience Plant Explosion Kills One Hexion Rejects Huntsman Shareholder Plan to Salvage BuyoutMonsanto, Evogene Team Up for Stress-Resistant GenesCalifornia Advances Ban on PFOA in Food Packaging Related Stories Cambridge Major Labs to Build Large-Scale U.S. FacilityLonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MDLonza Breaks Ground on Singapore Biologics PlantDSM Divests Biologics Plant; Focuses on Cell TechnologyAir Liquide Opens U.S. Research Complex

EnviroTech :: R&D

July 14, 2008

Lonza to Supply Stem Cell Therapy Drug to Maryland Biotech Firm

Alex Scott

Lonza says it has secured a deal with biotech firm Osiris Therapeutics (Columbia, MD) to manufacture what it says could be the world’s first stem cell drug. The agreement calls for Lonza to manufacture Osiris’s Prochymal stem cell therapy, which...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers